SCHEMBL1144971

SCHEMBL1144971

COc1c2cccc1Cc1cccc(c1O)Cc1cccc(c1OC)Cc1cccc(c1O)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTA1 P08263 5/20 0.41
GSTP1 P09211 5/20 0.41
PTPRC P08575 4/20 0.41
PTPN2 P17706 4/20 0.41
PTPN1 P18031 4/20 0.41
PTPRB P23467 4/20 0.41
PTPN11 Q06124 4/20 0.41
CD69 Q07108 1/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 3/20 0.40
CYP3A4 P08684 2/20 0.40
ALOX15 P16050 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
PDE4A P27815 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759347 1.00 GSTA1 (0.41) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL15541243 0.89 KDM4E (0.43) CD69ALDH1A1MAPTKDM4ECYP3A4
SCHEMBL12856781 0.87 GSTA1 (0.41) GSTA1GSTP1PTPRCPTPN2PTPN1
Hydroxyamine SCHEMBL11037119 0.86 CD69 (0.44) CD69ALDH1A1MAPTKDM4ECYP3A4
SCHEMBL1145207 0.85 GSTA1 (0.40) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL6690916 0.82 ELANE (0.45) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL8556505 0.82 GSTA1 (0.41) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL12856783 0.81 PTPRC (0.45) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL2471777 0.81 ALDH1A1 (0.48) GSTA1GSTP1PTPRCPTPN2PTPN1
SCHEMBL29366399 0.81 ALDH1A1 (0.48) GSTA1GSTP1PTPRCPTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230220158-A1 IONOMERS WITH MACROCYCLIC MOIETIES FOR ION CONDUCTIVITY AND PERMSELECTIVITY NATIONAL SCIENCE FOUNDATION 2023-07-13 US disclosed
US-20110028676-A1 Molecular Actuators, and Methods of Use Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-02-03 US disclosed
US-20110028676-A1 Molecular Actuators, and Methods of Use Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-02-03 US disclosed
US-7658868-B2 Class of molecular actuators where bulk actuation mechanisms such as ion intercalation are enhanced by controllable single molecule conformational rearrangements offers promise in exhibiting large active strains at moderate stresses MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-02-09 US disclosed
US-7658868-B2 Class of molecular actuators where bulk actuation mechanisms such as ion intercalation are enhanced by controllable single molecule conformational rearrangements offers promise in exhibiting large active strains at moderate stresses MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-02-09 US disclosed
US-20070215839-A1 Molecular actuators, and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-09-20 US disclosed
US-20070215839-A1 Molecular actuators, and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-09-20 US disclosed
US-7138075-B2 Molecular actuators, and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-11-21 US disclosed
US-20040007695-A1 Molecular actuators, and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-01-15 US disclosed
WO-2003101955-A2 MOLECULAR ACTUATORS, AND METHODS OF USE THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070215839-A1 Molecular actuators, and methods of use thereof NOD2, PIEZO1, TPR GSTA1 969/4885GSTP1 150/4885PTPRC 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.